30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective

Emerging evidence from the numerous clinical trials involving cytokine-induced killer (CIK) cell therapy suggests that its optimization in combination with other contemporary cancer therapies in a complementary manner (rather than as competition) will be a key to combat cancer.

Detalles Bibliográficos
Autores principales: Sharma, Amit, Schmidt-Wolf, Ingo G. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662881/
https://www.ncbi.nlm.nih.gov/pubmed/34886895
http://dx.doi.org/10.1186/s13046-021-02184-2
_version_ 1784613529380192256
author Sharma, Amit
Schmidt-Wolf, Ingo G. H.
author_facet Sharma, Amit
Schmidt-Wolf, Ingo G. H.
author_sort Sharma, Amit
collection PubMed
description Emerging evidence from the numerous clinical trials involving cytokine-induced killer (CIK) cell therapy suggests that its optimization in combination with other contemporary cancer therapies in a complementary manner (rather than as competition) will be a key to combat cancer.
format Online
Article
Text
id pubmed-8662881
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86628812021-12-13 30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective Sharma, Amit Schmidt-Wolf, Ingo G. H. J Exp Clin Cancer Res Commentary Emerging evidence from the numerous clinical trials involving cytokine-induced killer (CIK) cell therapy suggests that its optimization in combination with other contemporary cancer therapies in a complementary manner (rather than as competition) will be a key to combat cancer. BioMed Central 2021-12-09 /pmc/articles/PMC8662881/ /pubmed/34886895 http://dx.doi.org/10.1186/s13046-021-02184-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Commentary
Sharma, Amit
Schmidt-Wolf, Ingo G. H.
30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective
title 30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective
title_full 30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective
title_fullStr 30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective
title_full_unstemmed 30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective
title_short 30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective
title_sort 30 years of cik cell therapy: recapitulating the key breakthroughs and future perspective
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662881/
https://www.ncbi.nlm.nih.gov/pubmed/34886895
http://dx.doi.org/10.1186/s13046-021-02184-2
work_keys_str_mv AT sharmaamit 30yearsofcikcelltherapyrecapitulatingthekeybreakthroughsandfutureperspective
AT schmidtwolfingogh 30yearsofcikcelltherapyrecapitulatingthekeybreakthroughsandfutureperspective

Ejemplares similares